208 related articles for article (PubMed ID: 20426472)
21. A high-throughput screen for aggregation-based inhibition in a large compound library.
Feng BY; Simeonov A; Jadhav A; Babaoglu K; Inglese J; Shoichet BK; Austin CP
J Med Chem; 2007 May; 50(10):2385-90. PubMed ID: 17447748
[TBL] [Abstract][Full Text] [Related]
22. Polymer-mediated drug supersaturation - A spotlight on the interplay between phase-separated amorphous drug colloids and dissolved molecules.
Hirlak O; Dieluweit S; Merkel R; Wagner KG
J Colloid Interface Sci; 2021 Dec; 603():370-379. PubMed ID: 34197986
[TBL] [Abstract][Full Text] [Related]
23. Regional intestinal drug permeation: biopharmaceutics and drug development.
Lennernäs H
Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
[TBL] [Abstract][Full Text] [Related]
24. A Refined Developability Classification System.
Rosenberger J; Butler J; Dressman J
J Pharm Sci; 2018 Aug; 107(8):2020-2032. PubMed ID: 29665381
[TBL] [Abstract][Full Text] [Related]
25. Biorelevant Drug Solubility Enhancement Modeled by a Linear Solvation Energy Relationship.
Niederquell A; Kuentz M
J Pharm Sci; 2018 Jan; 107(1):503-506. PubMed ID: 28864357
[TBL] [Abstract][Full Text] [Related]
26. Ethanol effects on apparent solubility of poorly soluble drugs in simulated intestinal fluid.
Fagerberg JH; Al-Tikriti Y; Ragnarsson G; Bergström CA
Mol Pharm; 2012 Jul; 9(7):1942-52. PubMed ID: 22651218
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the light scattering and the turbidity microtiter plate-based methods for the detection of the excipient-mediated drug precipitation inhibition.
Petruševska M; Urleb U; Peternel L
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1148-56. PubMed ID: 24056092
[TBL] [Abstract][Full Text] [Related]
28. Influence of natural organic matter and ionic composition on the kinetics and structure of hematite colloid aggregation: implications to iron depletion in estuaries.
Mylon SE; Chen KL; Elimelech M
Langmuir; 2004 Oct; 20(21):9000-6. PubMed ID: 15461479
[TBL] [Abstract][Full Text] [Related]
29. In Vitro, in Silico, and in Vivo Assessments of Intestinal Precipitation and Its Impact on Bioavailability of a BCS Class 2 Basic Compound.
Kou D; Zhang C; Yiu H; Ng T; Lubach JW; Janson M; Mao C; Durk M; Chinn L; Winter H; Wigman L; Yehl P
Mol Pharm; 2018 Apr; 15(4):1607-1617. PubMed ID: 29522347
[TBL] [Abstract][Full Text] [Related]
30. Role of Self-Association and Supersaturation in Oral Absorption of a Poorly Soluble Weakly Basic Drug.
Narang AS; Badawy S; Ye Q; Patel D; Vincent M; Raghavan K; Huang Y; Yamniuk A; Vig B; Crison J; Derbin G; Xu Y; Ramirez A; Galella M; Rinaldi FA
Pharm Res; 2015 Aug; 32(8):2579-94. PubMed ID: 25724158
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the use of Classical Nucleation Theory for predicting intestinal crystalline precipitation of two weakly basic BSC class II drugs.
Carlert S; Lennernäs H; Abrahamsson B
Eur J Pharm Sci; 2014 Mar; 53():17-27. PubMed ID: 24345794
[TBL] [Abstract][Full Text] [Related]
32. The Effect of Promiscuous Aggregation on in Vitro Drug Metabolism Assays.
Tres F; Posada MM; Hall SD; Mohutsky MA; Taylor LS
Pharm Res; 2019 Oct; 36(12):170. PubMed ID: 31654151
[TBL] [Abstract][Full Text] [Related]
33. Mimicking regional and fasted/fed state conditions in the intestine with the mucus-PVPA in vitro model: The impact of pH and simulated intestinal fluids on drug permeability.
Falavigna M; Klitgaard M; Steene E; Flaten GE
Eur J Pharm Sci; 2019 Apr; 132():44-54. PubMed ID: 30822502
[TBL] [Abstract][Full Text] [Related]
34. Geometrical and Structural Dynamics of Imatinib within Biorelevant Colloids.
Wiest J; Saedtler M; Böttcher B; Grüne M; Reggane M; Galli B; Holzgrabe U; Meinel L
Mol Pharm; 2018 Oct; 15(10):4470-4480. PubMed ID: 30111113
[TBL] [Abstract][Full Text] [Related]
35. Leveraging bile solubilization of poorly water-soluble drugs by rational polymer selection.
Schlauersbach J; Hanio S; Lenz B; Vemulapalli SPB; Griesinger C; Pöppler AC; Harlacher C; Galli B; Meinel L
J Control Release; 2021 Feb; 330():36-48. PubMed ID: 33333120
[TBL] [Abstract][Full Text] [Related]
36. Colloidal aspects of dispersion and digestion of self-dispersing lipid-based formulations for poorly water-soluble drugs.
Vithani K; Jannin V; Pouton CW; Boyd BJ
Adv Drug Deliv Rev; 2019 Mar; 142():16-34. PubMed ID: 30677448
[TBL] [Abstract][Full Text] [Related]
37. Solubility at the molecular level: development of a critical aggregation concentration (CAC) assay for estimating compound monomer solubility.
Wang J; Matayoshi E
Pharm Res; 2012 Jul; 29(7):1745-54. PubMed ID: 22422319
[TBL] [Abstract][Full Text] [Related]
38. Rapid throughput solubility screening method for BCS class II drugs in animal GI fluids and simulated human GI fluids using a 96-well format.
Guo J; Elzinga PA; Hageman MJ; Herron JN
J Pharm Sci; 2008 Apr; 97(4):1427-42. PubMed ID: 17724660
[TBL] [Abstract][Full Text] [Related]
39. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies.
Cristofoletti R; Chiann C; Dressman JB; Storpirtis S
J Pharm Sci; 2013 Sep; 102(9):3136-44. PubMed ID: 23580377
[TBL] [Abstract][Full Text] [Related]
40. Dissolution behavior of various drugs in different FaSSIF versions.
Klumpp L; Leigh M; Dressman J
Eur J Pharm Sci; 2020 Jan; 142():105138. PubMed ID: 31704344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
